Michael P Kane, Pharm.D., FCCP, BCPS, BCACP

Bio: 

Education

  • Pharm.D., Medical University of South Carolina 
  • Clinical Pharmacy Resident, Adult Internal Medicine, Medical University Hospital Medical University of South Carolina, Charleston, SC
  • Hospital Pharmacy Resident, Greenwich Hospital Association Greenwich, CT 
  • B.S., Albany College of Pharmacy and Health Sciences

Courses Taught at ACPHS

  • Integrated Problem Solving Workshop 5 (Facilitator)
  • Integrated Problem Solving Workshop 4 (Facilitator)
  • PTPM Endocrinology
  • APPE - Ambulatory Care Endocrinology/Internal Medicine rotation

Research Interests

  • Assessing the safety and efficacy of new drugs in the management of diabetes mellitus and osteoporosis.

Selected Publications

Saroka RM, Kane MP, Robinson L, Busch RS. Case report of mifepristone use in a diabetes patient with unilateral cortisol-secreting adenomas: No post-operative steroids required. Submitted – Case Reports in Endocrinology.

Brady SM, Kane MP, Busch RS. GLP-1 Agonist Use in a Patient with an Explainable Cause of Pancreatitis. Accepted for publication - AACE Clinical Case Reports.

Kane MP. Hyperthyroidism: Graves’ Disease. In: Katz M, Matthias KR, Chisholm-Burns MA. Pharmacotherapy Principles and Practice Study Guide: A Case Based Care Plan Approach, 4th Edition. McGraw Hill: New York, NY, 2015; in press.

Kane MP. Endocrine Disorders. In: Bainbridge JL, Branham, A, Coyle EA, et al. Updates in Therapeutics®: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2015 ed. Lenexa, KS: American College of Clinical Pharmacy, 2015:1-39- 1-96.

Kane MP. Diabetes Mellitus. In: Bainbridge JL, Barbour SY, Coyle EA, et al. ACCP Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2012 ed. Lenexa, KS. American College of Clinical Pharmacy, 2012:1-135 - 1-168. 

Kane MP. Other Endocrine Disorders. In: Bainbridge JL, Barbour SY, Coyle EA, et al. ACCP Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Review and Recertification Course, 2012 ed. Lenexa, KS. American College of Clinical Pharmacy, 2012:1-169 – 1-216.

Traina AN, Kane MP, Bakst G, Busch RS, Abelseth JM, Hamilton RA. Efficacy of teriparatide in patients with resolved secondary hyperparathyroidism due to vitamin D deficiency. Endocrine Practice. 2011;17:4:568-73.

Traina AN, Kane MP, Bakst G, Abelseth JM, Busch RS. A Pharmacist-run Reclast Clinic. AJHP. 2011;68:1399-403.

Traina AN, Kane MP. A Primer on pramlintide: an amylin analog. Diabetes Educ. 2011;37:426-31.

Kane MP. Diabetes Mellitus. In: Bainbridge JL, Barbour SY, Coyle EA, et al. Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Review Course, 2011 ed. Lenexa, KS. American College of Clinical Pharmacy, 2011:1-71 - 1-100.

Kane MP. Other Endocrine Disorders. In: Bainbridge JL, Barbour SY, Coyle EA, et al. Updates in Therapeutics: Ambulatory Care Pharmacy Preparatory Review Course, 2011 ed. Lenexa, KS. American College of Clinical Pharmacy, 2011:1-101 – 1-142.

Traina AN, Kane MP. Hyperthyroidism Graves’ Disease. In: Katz M, Matthias KR, Chisholm-Burns MA. Pharmacotherapy Principles and Practice Study Guide: A Case Based Care Plan Approach. McGraw Hill: New York, NY, 2011; 191-4.

Traina AN, Kane MP. Chapter 49 - Adrenal Hormones. In: Smith KM, Riche DM, Henyan NN, editors. Clinical Drug Data (formerly Clinical Handbook of Drug Data). 11th ed. McGraw Hill; New York, NY, 2010;769-82.

Edwards KL, Riche DM, Stroup JS, Goldman-Levine JD, Padiyara RS, Cross LB, Kane MP. Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2010;30:955–65.

Kane MP, Abelseth, JM, Davis K, Hogan E, Hamilton RA. Clinical experience with a tubing-free insulin pump system. Infusystems USA. 2009;6:25-7.

Kane MP. Symposium on Off-label Drug Use. Off-label Drug Use: Pros and Cons. Albany Law Journal of Science and Technology. 2009;19(3):577-86.

Sheffield CA, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. Accuracy and Precision of Four Value-Added Blood Glucose Meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the Hypoguard Assure Pro. Diabetes Technol Ther. 2009;11:587-92.

Selected Poster/Platform Presentations

GLP-1 Agonists, SGLT-2 inhibitors and New Insulins: An Update in the Management of Diabetes. Presented to the Vermont Pharmacists Association, May 31, 2015, Montpelier, VT.

ACCP 2015 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 10, 2015, Rosemont, IL.

Saroka R, Kane MP, Busch RS, Watsky J, Hamilton RA. A six-month clinical perspective of canagliflozin added to GLP-1 therapy in the management of T2DM. Poster presented at the 2014 ASHP Midyear Clinical Meeting, December 10, 2014, Anaheim, CA.

Updates in Managing T2DM. Presented at Internal Medicine/Endocrinology Grand Rounds at Hartford Hospital, November 6, 2014, Hartford, CT.

Clinical Controversies, Fast and Furious - Male Testosterone Deficiency: Should it be treated? Presented at the American College of Clinical Pharmacy (ACCP) Annual Meeting, October 13, 2014, Austin, TX.

ACCP 2014 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Diabetes Mellitus. Presented the Diabetes section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 11, 2014, Rosemont, IL.

ACCP 2014 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented the Other Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 11, 2014, Rosemont, IL.

The Pharmacotherapy of Prediabetes. Grand Rounds, presented to pharmacists, physicians, nurse practitioners and physician assistants at The Endocrine Group; January 8, 2014, Albany, NY.

Nardolillo AM, Kane MP, Busch RS, Watsky J, Hamilton RA. Safety and Efficacy of Canagliflozin in the Management of T2DM. Poster presented at the 2013 ASHP Midyear Clinical Meeting, December 11, 2013, Orlando, FL.

Micale SJ, Khatounabadi S, Kane MP, Busch RA, Bakst G, Abelseth JM, Hamilton RA. Weekly-exenatide therapy: A Real-World Comparison of Incretin Therapies. Poster presented at the 2013 ACCP Annual Meeting, October 14, 2013, Albuquerque, NM.

Managing the complications of insulin resistance: glycemic control and beyond. Should metformin be the only option for pharmacotherapy in prediabetes. Pro/Con Debate. 2013 American College of Clinical Pharmacy Annual Meeting, October 14, 2013, Albuquerque, NM.

Glycemic control for adult patients with type 2 diabetes mellitus. Presented at the Pennsylvania Chapter of the American Society of Consultant Pharmacists annual meeting, September 21, 2013, Harrisburg, PA.

ACCP 2013 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Diabetes Mellitus. Presented the Diabetes section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 23, 2013, Reno, NV.

ACCP 2013 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented the Other Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 23, 2013, Reno, NV.

Western New York Society of Health-system Pharmacists – Annual CE Symposium: Therapeutic Updates in Endocrine Disorders. An Update in Thyroid Disease; Mar 23, 2013, Buffalo, NY. 

Connecticut Chapter of American Society of Consultant Pharmacists, Senior Symposium. Improving glycemic control for adult patients with Type 2 diabetes.  March 15, 2013; Mashantucket, CT.

Micale SJ, Kane MP, Busch RA, Hamilton RA. Effects of Denosumab on BMD in Primary Hyperparathyroid Patients Not Receiving Surgery. Poster presentation, 2012 ASHP Mid-Year Clinical Meeting, December 5, 2012, Las Vegas, NV.

ASHP MCM 2012 Debates in Therapeutics session: Once Daily vs. Once Weekly  Vitamin D. The 2012 ASHP Midyear Clinical Meeting, December 5, 2012, Las Vegas, NV.

Improving glycemic control for adult patients with Type 2 diabetes. The American Society of Consultant Pharmacists, Annual Meeting, November 8, 2012; National Harbor, MD.

Improving glycemic control for adult patients with Type 2 diabetes. The National Community Pharmacists Association’s 114th Annual Convention and Trade Exposition, October 14, 2012, San Diego, CA. 

The Non-Glycemic Management of Diabetes. Presented at the Experience & Professional Learning Opportunities Result in Excellence (EXPOLORE) Diabetes Conference: Diabetes in the 21st Century: Raising the Bar, May 22, 2012, Plattsburgh, NY.

ACCP 2012 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Diabetes Mellitus. Presented the Diabetes section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented made April 27, 2012, Reno, NV.

ACCP 2012 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented the Other Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presented April 27, 2012, Reno, NV.

Diabetes Management in the Elderly; Part of the Annual Pharmacy Practice Institute. Presented March 16, 2012, Albany, NY.

Diabetes Update. Presented at the APhA Annual Meeting, New Orleans, LA, March 11, 2012.

Heh AM, Kane MP, Hamilton RA, Busch RS, Bakst G, Abelseth JM, Belletti DA. Mono and Dual Renin-Angiotensin-Aldosterone-System Inhibition Strategies in Hypertensive Type 2 Diabetes Mellitus Patients with Proteinuria: Safety and Efficacy Experiences of an Endocrinology Practice. Poster presented at the Society of General Internal Medicine 36th Annual Meeting, May 10, 2012, Orlando, FL.

ACCP 2012 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Diabetes Mellitus. Presented the Diabetes section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presentation made April 27, 2012, Reno, NV.

ACCP 2012 Updates In Therapeutics: The Ambulatory Care Pharmacy Preparatory Review Course; Other Endocrine Disorders. Presented the Other Endocrine Disorders section of the Ambulatory Care Pharmacy Preparatory Review Course which is offered in preparation of the pharmacy Specialty Certification Examination for Board Certification in Ambulatory Care. Presentation made April 27, 2012, Reno, NV.

Diabetes Management in the Elderly; Part of the Annual Pharmacy Practice Institute. Presented March 16, 2012, Albany, NY.

Diabetes Update. Presented at the APhA Annual Meeting, New Orleans, LA, March 11, 2012.

Senior Perspectives: Diabetes Care for Older Adults. Presented at the PharmEd Continuing Education Program, September 15, 2011, Albany, NY.

A Pharmacist-managed Osteoporosis Clinic. Presented at the 50th Annual Assembly of the New York State Council of Health-systems Pharmacists:  Basic to Clinical Application:  Management of Endocrine and Metabolic Disorders, April 30, 2011, Verona, NY.

Back to Basics and Beyond: A Review of Diabetes Mellitus. Presented at the 50th Annual Assembly of NYSCHP:  Basic to Clinical Application:  Management of Endocrine and Metabolic Disorders, April 29, 2011, Verona, NY.

Greenberg B, Traina AN, Kane MP, Busch RS, Bakst G, Abelseth JM. The ezetimibe to cholesevelam switch study. Poster presented at the 2010 American College of Clinical Pharmacy Spring Practice and Research Forum, April 24, 2010, Charlotte, NC. 

Traina AN, Kane MP, Hamilton RA, Busch RS, Bakst G, Abelseth JM. A glucose meter accuracy study: A comparison of the Yellow Springs Instrument with venous laboratory glucose measurements and plasma-calibrated value-added, auto-coded glucose meters. Poster presented at the 2010 American College of Clinical Pharmacy Spring Practice and Research Forum, April 24, 2010, Charlotte, NC. 

Traina AN, Kane MP, Hamilton RA, Busch RS, Bakst G, Abelseth JM. Efficacy of teriparatide in patients with resolved secondary hyperparathyroidism due to vitamin D deficiency. Poster presented at the 2010 American College of Clinical Pharmacy Spring Practice and Research Forum, April 24, 2010, Charlotte, NC. 

Traina AN, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. Triple renin-angiotensin-aldosterone-system (RASS) inhibition: safety and efficacy of the angiotensin-converting enzyme inhibitor, angiotensisn II receptor blocker and direct renin inhibition combination therapy. Poster presented at the 2009 American College of Clinical Pharmacy/European Society of Clinical Pharmacy International Congress on Clinical Pharmacy, April 26, 2009, Orlando, FL. 

Dropkin BM, Traina AN, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. The safety and efficacy of sitagliptin and insulin in Type 2 Diabetes. Poster presented at the 2009 American College of Clinical Pharmacy/European Society of Clinical Pharmacy International Congress on Clinical Pharmacy, April 25, 2009, Orlando, FL. 

Traina AN, Sheffield CA, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA. Glucose meter accuracy study: correlation of the Yellow Springs Instrument with venous laboratory glucose measurements and popular plasma-calibrated glucose meters. Poster presented at the 2008 ASHP Midyear Clinical Meeting, December 10, 2008, Orlando, FL.

Fox ML, Kane MP, Busch RS, Hamilton RA. Safety of zoledronic acid in the management of osteoporosis. Poster presented at the American College of Clinical Pharmacy 2008 Annual Meeting, October 20, 2008, Louisville, KY. 

Kane MP, Abelseth JM, Davis K, Hogan E, Hamilton RA. Clinical experience with a tubeless insulin pump system. Poster presented at the American Association of Diabetes Educators 35th Annual Meeting and Exhibition, August 6, 2008, Washington, D.C.

Research Grants

Weekly-Exenatide Therapy: A Real-World Comparison of Incretin Therapies. Kane MP, Micale SJ, Busch RS, Bakst G, Abelseth JM, Hamilton RA. Albany College of Pharmacy and Health Sciences, and The Endocrine Group. Awarded $44,875; Bristol-Myers Squibb Pharmaceuticals, Inc; 9/12.

 A retrospective analysis of the effects of progression from single to dual RAAS inhibition on BP, serum potassium, serum creatinine, and albuminuria in hypertensive type 2 diabetes patients. Kane MP, Heh A, Bakst G, Busch RS, Abelseth JM, Hamilton RA. Albany College of Pharmacy and Health Sciences, and The Endocrine Group. Awarded $64,500; Novartis Pharmaceuticals; 12/10. 

A Glucose Meter Accuracy Study: A Comparison of the Yellow Springs Instrument with Venous Laboratory Glucose Measurements and Plasma-Calibrated Value-Added Glucose Meters. Kane MP, Traina AN, Bakst G, Busch RS, Abelseth JM, Hamilton RA. Albany College of Pharmacy and Health Sciences, and The Endocrine Group. Awarded $49,991.59; Abbott Diabetes Care; 9/09. 

Efficacy of Teriparatide in Patients with Resolved Secondary Hyperparathyroidism due to Vitamin D Deficiency. Kane MP, Traina AN, Busch RS. Albany College of Pharmacy and Health Sciences, and The Endocrine Group. Awarded $22,500; Eli Lilly and Company; 7/09.

Honors and Appointments

  • Recipient of the 2010 American College of Clinical Pharmacy, Clinical Practice Award; presented October 14, 2010, Austin, TX
  • Appointed to Board of Trustees of Northeast Kidney Foundation in 2015

Clinical Affiliations

  • Clinical Pharmacy Specialist – Albany Medical Center Division of Community Endocrinology (The Endocrine Group), Albany, NY
  • Preceptor – Residency in Adult Internal Medicine/Endocrinology
  • Fellow of the American College of Clinical Pharmacy
  • Board Certified in Pharmacotherapy (since 1991)
  • Board Certified in Ambulatory Care Pharmacy (since 2011)
Professor
Department of Pharmacy Practice